Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Human Genetics, |
RCV000659321 | SCV000781132 | likely benign | Connective tissue disorder | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001731852 | SCV001982220 | uncertain significance | not provided | 2023-08-02 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Not observed at a significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Reported in ClinVar (ClinVar Variant ID# 547209; ClinVar) |
Invitae | RCV001731852 | SCV002130263 | benign | not provided | 2023-11-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003243245 | SCV003965691 | uncertain significance | Inborn genetic diseases | 2023-03-17 | criteria provided, single submitter | clinical testing | The c.3698A>G (p.N1233S) alteration is located in exon 48 (coding exon 48) of the COL11A1 gene. This alteration results from a A to G substitution at nucleotide position 3698, causing the asparagine (N) at amino acid position 1233 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |